Action

SBA Recognizes 2024 Government Contractors and 8(a) Graduate of the Year

Retrieved on: 
Friday, April 5, 2024
Knowledge, Forecasting, Growth, SBA, Action, Federation, Business, Systems analysis, National Small Business Week, Electronics, Research, Business development, Small business, Private sector, APEX, Homeland security, NASA, The, Engineering, Air force, Texas A&M University, Senior counsel, Excellence, Government, KBSI, Navy, Army, Construction

These fuzes are used in electro-mechanical rocket, missile, artillery, mortar, and tank devices for the Department of Defense and domestic prime contractors.

Key Points: 
  • These fuzes are used in electro-mechanical rocket, missile, artillery, mortar, and tank devices for the Department of Defense and domestic prime contractors.
  • Cetechs won the 2018 SBA Emerging Leaders Program Graduate Award, the 2019 Arizona Small Business Development Center Success Award, and the 2020 Goldman Sachs Award.
  • The Dwight D. Eisenhower Award for Excellence recognizes other small business prime contractors that have excelled in utilizing small businesses as suppliers and subcontractors within various industries.
  • Additionally, it collaborated with various SBA District Offices, Small Business Development Centers, and APEX Accelerators to educate and network with small businesses.

Notice of Pendency of Class Action Involving All Persons and Entities who Held Shares of Alta Mesa Silver Run II Common Stock and Purchased or Otherwise Acquired Securities of Alta Mesa / Silver Run II

Retrieved on: 
Monday, April 8, 2024
COMMON, Class Action, PART, Documentation, Action, Alta Mesa AVA, Riverstone Holdings, Notice, Business, Silver, District court, Defendant, ALL, CUSIP, Class, AMH, ARM, Business analyst, Motion, Judgement, CLASS, AMR, HPS, Lis pendens, Court, Docket (court), Person

IN RE ALTA MESA RESOURCES, INC.

Key Points: 
  • IN RE ALTA MESA RESOURCES, INC.
    TO: (1) ALL PERSONS AND ENTITIES WHO HELD SHARES OF ALTA MESA (SILVER RUN II) COMMON STOCK AND/OR SILVER RUN II UNITS ON JANUARY 22, 2018; AND (2) ALL PERSONS AND ENTITIES WHO PURCHASED OR OTHERWISE ACQUIRED SECURITIES OF ALTA MESA / SILVER RUN II FROM AUGUST 16, 2017 THROUGH MAY 17, 2019, INCLUSIVE (THE "CLASS PERIOD").
  • THIS NOTICE IS NOT A SETTLEMENT NOTICE AND YOU ARE NOT BEING ASKED TO SUBMIT A CLAIM AT THIS TIME.
  • HOWEVER, IF YOU ARE A MEMBER OF THE CLASS, YOUR RIGHTS WILL BE AFFECTED BY THIS ACTION.
  • This is a securities class action against Defendants for alleged violations of the federal securities laws.

Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Entered into a Definitive Mutual Release and Settlement Agreement with Virpax Pharmaceuticals, Inc. Relating to the Previously Announced Term Sheet with Virpax in Respect of Su

Retrieved on: 
Friday, March 15, 2024
Bankruptcy, Plaintiff, Action, Sale, Chronic pain, United States bankruptcy court, Settlement, PALO, Court, Nursing

The Definitive Settlement Agreement relates to the term sheet previously announced by Scilex on February 26, 2024, regarding a mutual release and settlement agreement between Scilex Pharma, Sorrento and Virpax in respect of the action (the “Action”) filed by Scilex Pharma and Sorrento (together, the “Plaintiffs”) against Anthony Mack, former President of Scilex Pharma and Virpax, a company founded and then headed by Mr. Mack.

Key Points: 
  • The Definitive Settlement Agreement relates to the term sheet previously announced by Scilex on February 26, 2024, regarding a mutual release and settlement agreement between Scilex Pharma, Sorrento and Virpax in respect of the action (the “Action”) filed by Scilex Pharma and Sorrento (together, the “Plaintiffs”) against Anthony Mack, former President of Scilex Pharma and Virpax, a company founded and then headed by Mr. Mack.
  • The Plaintiffs’ release relates to claims against Virpax only, which does not affect their claims against Mr. Mack.
  • Plaintiffs’ release as to Virpax is conditioned upon Virpax’s Initial Payment.
  • For more information on Gloperba®, including Full Prescribing Information, refer to www.gloperba.com .

Scott+Scott Attorneys at Law LLP & Hedin Hall LLP Announce Notice of Class Action and Proposed Settlement to All Who Purchased or Acquired Shares of Viatris Inc. Pursuant to a November 2020 Merger of Mylan N.V. and Upjohn, Inc. to Form Viatris

Retrieved on: 
Monday, March 11, 2024
Class Action Lawsuit, Professional Services, Legal, Claim, Agreement, Prejudice, Action, Defendant, Summons, Person, Viatris, CLASS, ARE, Settlement, Court of Common Pleas, Pfizer, Court, Hearing, Law, Generic drug

YOUR RIGHTS MAY BE AFFECTED BY A CLASS ACTION LAWSUIT PENDING IN THIS COURT.

Key Points: 
  • YOUR RIGHTS MAY BE AFFECTED BY A CLASS ACTION LAWSUIT PENDING IN THIS COURT.
  • A hearing will be held on June 12, 2024 at 1:00 p.m. Eastern Time, before the Hon.
  • Please do not contact the Court, the Clerk’s office, Viatris, the other Defendants, or their counsel regarding this notice.
  • All questions about this notice, the proposed Settlement, or your eligibility to participate in the Settlement should be directed to Lead Counsel or the Claims Administrator.

Settlement Administrator Angeion Group Announces Proposed Settlements with Brown University, University of Chicago, the Trustees of Columbia University in the City of New York, Trustees of Dartmouth College, Duke University, Emory University, Northwestern

Retrieved on: 
Friday, March 29, 2024
Vanderbilt University, Tax, University, Action, Hearing, Summons, City, Emory University, University of Chicago, Class, Dartmouth College, Brown University, Fairness, Info, Massachusetts Institute of Technology, District court, Cornell University, Georgetown University, Defendant, Student, Rice, Settlement, Claim, California Institute of Technology, PC, University of Pennsylvania, Plaintiff, Trustee, School, University of Notre Dame, Columbia University, Johns Hopkins University, Pharmaceutical industry

PHILADELPHIA, March 29, 2024 /PRNewswire/ -- A federal court has preliminarily approved proposed settlements ("Settlements") with the following ten defendant universities: Brown University ("Brown"), University of Chicago ("Chicago"), the Trustees of Columbia University in the City of New York ("Columbia"), Trustees of Dartmouth College ("Dartmouth"), Duke University ("Duke"), Emory University ("Emory"), Northwestern University ("Northwestern"), William Marsh Rice University ("Rice"), Vanderbilt University ("Vanderbilt") and Yale University ("Yale"). The Court has also preliminarily approved a Settlement Class of students who attended the following seventeen schools (during certain time periods): Brown, California Institute of Technology, Chicago, Columbia, Cornell University, Dartmouth, Duke, Emory, Georgetown University, Johns Hopkins University, Massachusetts Institute of Technology, Northwestern, University of Notre Dame, University of Pennsylvania, Rice, Vanderbilt, and Yale (the "Defendants," or "Universities," or "Defendant Universities"). As a part of the Settlement, the Defendant Universities have agreed to make a settlement payment of $284 million and to provide certain additional information to Plaintiffs in this antitrust class action lawsuit called Henry, et al. v. Brown University, et al., 1:22-cv-00125, pending in the United States District Court for the Northern District of Illinois ("Action").

Key Points: 
  • PHILADELPHIA, March 29, 2024 /PRNewswire/ -- A federal court has preliminarily approved proposed settlements ("Settlements") with the following ten defendant universities: Brown University ("Brown"), University of Chicago ("Chicago"), the Trustees of Columbia University in the City of New York ("Columbia"), Trustees of Dartmouth College ("Dartmouth"), Duke University ("Duke"), Emory University ("Emory"), Northwestern University ("Northwestern"), William Marsh Rice University ("Rice"), Vanderbilt University ("Vanderbilt") and Yale University ("Yale").
  • v. Brown University, et al., 1:22-cv-00125, pending in the United States District Court for the Northern District of Illinois ("Action").
  • The Action was brought by certain students who attended the Universities while receiving partial need-based financial aid.
  • The Action alleges that the Universities conspired in violation of the federal antitrust laws regarding principles, formulas, and methods of determining financial aid.

Bernstein Litowitz Berger and Grossmann LLP Announces Notice of Pendency and Proposed Settlement of Class Action Involving Persons or Entities who Purchased or Otherwise Acquired Publicly Traded Ryder System, Inc. Common Stock During the Period from July

Retrieved on: 
Monday, March 18, 2024
Ryder, Claim, Class Action, Stipulation, System, Agreement, Prejudice, Action, Notice, Telephone, District court, Hearing, Motion, Clerk, CLASS, ARE, Settlement, Counsel, Lawsuit, Release, Person, Generic drug

Ryder System, Inc. ("Ryder") common stock during the period from July 23, 2015 through

Key Points: 
  • Ryder System, Inc. ("Ryder") common stock during the period from July 23, 2015 through
    PLEASE READ THIS NOTICE CAREFULLY.
  • YOUR RIGHTS WILL BE AFFECTED BY A CLASS ACTION LAWSUIT PENDING IN THIS COURT.
  • Certain persons and entities are excluded from the Settlement Class by definition, as set forth in the full Notice of (I) Pendency of Class Action and Proposed Settlement; (II) Settlement Hearing; and (III) Motion for Attorneys' Fees and Litigation Expenses (the "Notice"), available at www.RyderSystemSecuritiesLitigation.com .
  • YOU ARE ALSO NOTIFIED that Lead Plaintiffs in the Action, on behalf of themselves and the Settlement Class, have reached a proposed settlement of the Action for $45,000,000 in cash (the "Settlement").

Notice of Proposed Settlement Affecting All Persons who Purchased or Acquired FibroGen, Inc. Securities, Including Options, Between December 20, 2018 through July 15, 2021

Retrieved on: 
Monday, March 18, 2024
Action, Notice, District court, United States district court, Summons, PACER, Clerk, Settlement, Public access, Insurance

PLEASE DO NOT CONTACT THE COURT, THE CLERK'S OFFICE, DEFENDANTS, OR DEFENDANTS' COUNSEL REGARDING THIS NOTICE, THE PROPOSED SETTLEMENT, OR THE CLAIMS PROCESS.

Key Points: 
  • PLEASE DO NOT CONTACT THE COURT, THE CLERK'S OFFICE, DEFENDANTS, OR DEFENDANTS' COUNSEL REGARDING THIS NOTICE, THE PROPOSED SETTLEMENT, OR THE CLAIMS PROCESS.
  • You cannot ask the Court to order a different settlement; the Court can only approve or reject the Settlement.
  • If the Court denies approval, no settlement payments will be sent out, and the lawsuit will continue.
  • 21-cv-02623) and include all information required by the Court as detailed in the Notice.

Scott+Scott Attorneys at Law LLP & Hedin Hall LLP Announce Notice of Class Action and Proposed Settlement to All Who Purchased or Acquired Shares of Viatris Inc. Pursuant to a November 2020 Merger of Mylan N.V. and Upjohn, Inc. to Form Viatris

Retrieved on: 
Monday, March 11, 2024
Claim, Agreement, Prejudice, Action, Defendant, Summons, Person, Fee, Clerk, Viatris, ARE, Settlement, Counsel, Court of Common Pleas, Pfizer, Court, Hearing, Law, Generic drug

your rights MAY be affected by a class action lawsuit pending in this court.

Key Points: 
  • your rights MAY be affected by a class action lawsuit pending in this court.
  • A hearing will be held on June 12, 2024 at 1:00 p.m. Eastern Time, before the Hon.
  • Please do not contact the Court, the Clerk's office, Viatris, the other Defendants, or their counsel regarding this notice.
  • All questions about this notice, the proposed Settlement, or your eligibility to participate in the Settlement should be directed to Lead Counsel or the Claims Administrator.

Litigation Update - Knightscope Authorized to Serve Notice of Action Against Capybara Research by Public Disclosure and Press Release Pursuant to Court Order

Retrieved on: 
Friday, March 1, 2024
Technology, Robotics, Hardware, Security, Form 8-K, Research, Multimedia, District court, Complaint, Action, Court order, Knightscope, ECF, Security (finance), Update

On December 20, 2023, Knightscope, Inc. [Nasdaq: KSCP] (“Knightscope” or the “Company”) filed a federal lawsuit in the United States District Court for the Southern District of New York, Knightscope, Inc. v. Capybara Research et.

Key Points: 
  • On December 20, 2023, Knightscope, Inc. [Nasdaq: KSCP] (“Knightscope” or the “Company”) filed a federal lawsuit in the United States District Court for the Southern District of New York, Knightscope, Inc. v. Capybara Research et.
  • 1:23-cv-11050-DLC (the “Action”) against Capybara Research, Igor Appelboom (“Appelboom,” and together with Capybara Research, the “Capybara Defendants”), and Accretive Capital LLC d/b/a Benzinga.
  • View the full release here: https://www.businesswire.com/news/home/20240229740998/en/
    Litigation Update - Knightscope Authorized to Serve Notice of Action Against Capybara Research by Public Disclosure and Press Release Pursuant to Court Order (Graphic: Business Wire)
    The Action alleges that the Capybara Defendants take short positions in publicly traded companies and release fraudulent, disparaging reports in order to drive the company’s stock price down for their own financial benefit.
  • Pursuant to the Order of The Honorable Denise L. Cote in the United States District Court for the Southern District of New York, entered on January 29, 2024 (ECF 29), in the matter of Knightscope, Inc. v. Capybara Research et.

Bernstein Litowitz Berger & Grossmann LLP and Saxena White P.A. Announce Pendency of Class Action And Proposed Settlement For All Persons And Entities Who Purchased or Otherwise Acquired the Common Stock of James River Group Holdings, Ltd., During the Per

Retrieved on: 
Monday, March 4, 2024
Exchange, Court, READ, Hearing, Clerk, Post office box, Person, ARE, Release, City, Claim, The Honourable, Net settlement, Prejudice, Summons, District court, Fort Worth, Texas, Action, CLASS, Notice, Settlement, Pension, Stipulation, Counsel, Insurance

YOUR RIGHTS WILL BE AFFECTED BY A CLASS ACTION LAWSUIT PENDING IN THIS COURT.

Key Points: 
  • YOUR RIGHTS WILL BE AFFECTED BY A CLASS ACTION LAWSUIT PENDING IN THIS COURT.
  • If approved, the Settlement will resolve all claims in the Action.
  • The Action involves allegations that James River and certain of its senior officers violated federal securities laws.
  • All questions about this notice, the proposed Settlement, or your eligibility to participate in the Settlement should be directed to the Claims Administrator or Lead Counsel.